Riverview Trust Company’s Gilead Sciences GILD Stock Holding History

Riverview Trust Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,494	Closed	-$167K	–	360
2025 Q1	$167K	Sell	1,494 -25	-2%	-$2.58K	0.17%	110
2024 Q4	$140K	Hold	1,519	–	–	0.13%	125
2024 Q3	$127K	Buy	1,519 +25	+2%	+$1.91K	0.11%	139
2024 Q2	$103K	Sell	1,494 -1,830	-55%	-$122K	0.1%	153
2024 Q1	$243K	Hold	3,324	–	–	0.19%	82
2023 Q4	$269K	Hold	3,324	–	–	0.27%	80
2023 Q3	$249K	Hold	3,324	–	–	0.22%	77
2023 Q2	$256K	Hold	3,324	–	–	0.23%	70
2023 Q1	$276K	Hold	3,324	–	–	0.25%	68
2022 Q4	$285K	Hold	3,324	–	–	0.27%	65
2022 Q3	$205K	Buy	3,324 +482	+17%	+$30.4K	0.2%	86
2022 Q2	$176K	Hold	2,842	–	–	0.15%	106
2022 Q1	$169K	Buy	2,842 +1,012	+55%	+$64.7K	0.13%	107
2021 Q4	$133	Hold	1,830	–	–	0.08%	104
2021 Q3	$128K	Hold	1,830	–	–	0.14%	105
2021 Q2	$126K	Hold	1,830	–	–	0.13%	105
2021 Q1	$118K	Hold	1,830	–	–	0.13%	107
2020 Q4	$107K	Hold	1,830	–	–	0.12%	112
2020 Q3	$116K	Hold	1,830	–	–	0.13%	102
2020 Q2	$141K	Hold	1,830	–	–	0.14%	105
2020 Q1	$137K	Hold	1,830	–	–	0.13%	101
2019 Q4	$119K	Hold	1,830	–	–	0.08%	133
2019 Q3	$116K	Hold	1,830	–	–	0.08%	129
2019 Q2	$124K	Hold	1,830	–	–	0.09%	122
2019 Q1	$119K	Hold	1,830	–	–	0.09%	121
2018 Q4	$114K	Buy	+1,830	New	+$128K	0.09%	114

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Riverview Trust Company's GILD Position: Q2 2025 in Review

Riverview Trust Company sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 1,494 shares — an estimated $167K sold.

Riverview Trust Company first reported a position in GILD in Q4 2018 and held it in 26 quarters. The position peaked at $285K in Q4 2022. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

Riverview Trust Company reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
Riverview Trust Company sold 1,494 Gilead Sciences shares in Q2 2025, an estimated $167K.
Riverview Trust Company first reported a position in Gilead Sciences in Q4 2018 and held it in 26 quarters.
Riverview Trust Company's Gilead Sciences position peaked at $285K in Q4 2022.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Riverview Trust Company's 13F filing for Q2 2025, filed 21 Jul 2025.